Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 100  

    Article Cited by others

ORIGINAL ARTICLE

Metastatic neuroendocrine tumor with extensive bone marrow involvement at diagnosis: Evaluation of response and hematological toxicity profile of PRRT with 177Lu-DOTATATE

Basu Sandip, Ranade Rohit, Thapa Pradeep

Year : 2016| Volume: 15| Issue : 1 | Page no: 38-43

   This article has been cited by
 
1 Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis
Ruben Mujica-Mota,Jo Varley-Campbell,Irina Tikhonova,Chris Cooper,Ed Griffin,Marcela Haasova,Jaime Peters,Stefano Lucherini,Juan Talens-Bou,Linda Long,David Sherriff,Mark Napier,John Ramage,Martin Hoyle
Health Technology Assessment. 2018; 22(49): 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article